Wells Fargo
TYRA icon

Wells Fargo’s Tyra Biosciences TYRA Stock Holding History

Wells Fargo’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$447K Sell
11,672
-17,377
-60% -$563K ﹤0.01% 4240
2025
Q4 		$764K Buy
29,049
+10,579
+57% +$194K ﹤0.01% 4171
2025
Q3 		$258K Buy
18,470
+3,013
+19% +$34.4K ﹤0.01% 4783
2025
Q2 		$148K Buy
15,457
+6,104
+65% +$58K ﹤0.01% 4945
2025
Q1 		$87K Sell
9,353
-140
-1% -$1.81K ﹤0.01% 5174
2024
Q4 		$132K Buy
9,493
+3,236
+52% +$58.7K ﹤0.01% 5043
2024
Q3 		$147K Sell
6,257
-249
-4% -$5.23K ﹤0.01% 4777
2024
Q2 		$104K Buy
6,506
+1,781
+38% +$30.7K ﹤0.01% 4919
2024
Q1 		$77.5K Buy
4,725
+652
+16% +$10.7K ﹤0.01% 5044
2023
Q4 		$56.4K Buy
4,073
+843
+26% +$10.9K ﹤0.01% 5227
2023
Q3 		$44.5K Sell
3,230
-2,282
-41% -$33.8K ﹤0.01% 5241
2023
Q2 		$93.9K Buy
5,512
+3,150
+133% +$45.7K ﹤0.01% 5081
2023
Q1 		$38K Buy
+2,362
New +$28.1K ﹤0.01% 5310
2022
Q4 		– Sell
-39
Closed – – 7736
2022
Q3 		$0 Sell
39
-114
-75% -$1.04K ﹤0.01% 7391
2022
Q2 		$1K Sell
153
-2,409
-94% -$19.2K ﹤0.01% 6618
2022
Q1 		$27K Sell
2,562
-4,489
-64% -$53.3K ﹤0.01% 5913
2021
Q4 		$99K Buy
+7,051
New +$140K ﹤0.01% 5644

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Wells Fargo's TYRA Position: Q1 2026 in Review

Wells Fargo reduced its Tyra Biosciences (TYRA) stake by 60% in Q1 2026, selling an estimated $563K and leaving 11,672 shares worth $447K. The position accounts for ﹤0.01% of the portfolio, ranked #4240.

Wells Fargo first reported a position in TYRA in Q4 2021 and has held it in 17 quarters since. The position peaked at $764K in Q4 2025. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Wells Fargo held 11,672 shares of Tyra Biosciences worth $447K as of Q1 2026.
  • Wells Fargo sold 17,377 Tyra Biosciences shares in Q1 2026, an estimated $563K.
  • Tyra Biosciences made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4240 holding.
  • Wells Fargo first reported a position in Tyra Biosciences in Q4 2021 and has held it in 17 quarters since.
  • Wells Fargo's Tyra Biosciences position peaked at $764K in Q4 2025.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.